Product — Product revenues, net
Vertex Pharmaceuticals Product — Product revenues, net increased by 3.7% to $3.19B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 9.5%, from $2.91B to $3.19B. Over 4 years (FY 2021 to FY 2025), Product — Product revenues, net shows an upward trend with a 12.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates successful market penetration, strong demand for existing therapies, or the successful launch of new products. A decrease may signal increased competition, patent expirations, or pricing pressure within the biotechnology sector.
Detailed definition
This metric represents the total net revenue generated from the sale of pharmaceutical products after accounting for ret...
Peer comparison
This is a standard top-line revenue metric across the biopharmaceutical industry, comparable to 'Net Product Sales' reported by peers like Amgen or Gilead.
vrtx_segment_product_revenues_net_product_revenues_netHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.79B | $1.98B | $2.07B | $2.10B | $2.20B | $2.33B | $2.30B | $2.47B | $2.47B | $2.47B | $2.47B | $2.69B | $2.65B | $2.77B | $2.91B | $2.76B | $2.94B | $3.08B | $3.19B |
| QoQ Change | — | +10.6% | +4.5% | +1.2% | +4.7% | +6.3% | -1.4% | +7.1% | +0.0% | +0.0% | +0.0% | +9.1% | -1.7% | +4.8% | +5.1% | -5.2% | +6.7% | +4.5% | +3.7% |
| YoY Change | — | — | — | — | +22.5% | +17.6% | +11.1% | +17.6% | +12.3% | +5.7% | +7.1% | +9.1% | +7.2% | +12.3% | +18.0% | +2.6% | +11.3% | +11.0% | +9.5% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's product — product revenues, net?
- Vertex Pharmaceuticals (VRTX) reported product — product revenues, net of $3.19B in Q4 2025.
- How has Vertex Pharmaceuticals's product — product revenues, net changed year-over-year?
- Vertex Pharmaceuticals's product — product revenues, net increased by 9.5% year-over-year, from $2.91B to $3.19B.
- What is the long-term trend for Vertex Pharmaceuticals's product — product revenues, net?
- Over 4 years (2021 to 2025), Vertex Pharmaceuticals's product — product revenues, net has grown at a 12.1% compound annual growth rate (CAGR), from $7.57B to $11.97B.
- What does product — product revenues, net mean?
- The total amount of money earned from selling pharmaceutical products after subtracting sales-related deductions.